Zai Lab Shares Up 11% as Repotrectinib Gets Breakthrough Therapy Designation in China
By Sabela Ojea Shares of Zai Lab on Wednesday climbed after the biotechnology company said the Center for Drug Evaluation of China's National Medical...
Source: marketwatch.com